Stella Diagnostics Company Description

Stella Diagnostics, Inc., a research diagnostics company, engages in developing molecular diagnostics tools and new drug targets for esophageal diseases.

It uses targeted mass spectrometry to determine the level of disease progression in tissue of the lower esophagus.

The company’s technology notifies gastroenterologists, surgical oncologists, and pathologists, which patients are high risk for disease progression into precancer or cancer.

The company was formerly known as JMP Properties, Inc. and changed its name to Stella Diagnostics, Inc. in April 2021.

Stella Diagnostics, Inc. is headquartered in Salt Lake City, Utah.

Stella Diagnostics, Inc.

Country	United States
Industry	Diagnostics & Research
Sector	Healthcare
Employees	2
CEO	David Seaburg

Contact Details

Address: 50 West Broadway Salt Lake City, Florida 84101 United States
Phone	201 381 1474
Website	stelladx.com

Stock Details

Ticker Symbol	SLDX
Exchange	OTCMKTS
Stock Type	Common Stock
Fiscal Year	January - December
Reporting Currency	USD
ISIN Number	US85853Y1047
SIC Code	8071

Key Executives

Name	Position
David B. Seaburg	Chief Executive Officer and Director